Anouk A M T Donners (Anouk Donners)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

BMJ open

Research and practice in thrombosis and haemostasis

International journal of laboratory hematology

Haemophilia : the official journal of the World Federation of Hemophilia

University Medical Center Utrecht

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center Utrecht Jan 01 2016

Netherlands

PhD-candidate :: Clinical Pharmacy

Publications

Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Shweta Bansal, Anouk A M T Donners, Kathelijn Fischer, Kathelijn Fischer, Savita Rangarajan, Varsha Phadke, Shrutika Mhatre, Bharati Sontate, Magdelene D' Silva, Shahana Ansari, Shrimati Shetty
Low dose emicizumab prophylaxis in haemophilia a patients: A pilot study from India. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Anouk A M T Donners, László Gerencsér, Kim C M van der Elst, Antoine C G Egberts, Moniek P M de Maat, Albert Huisman, Rolf T Urbanus, Mohsin El Amrani
Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Anouk A M T Donners, Carin M A Rademaker, Lisanne A H Bevers, Alwin D R Huitema, Roger E G Schutgens, Antoine C G Egberts, Kathelijn Fischer
Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review. Clinical pharmacokinetics 60 (11) (2021)
Anouk A M T Donners, Erik M van Maarseveen, Yrea R J Weetink, Mohsin El Amrani, Kathelijn Fischer, Carin M A Rademaker, Toine C G Egberts, Albert Huisman, Ruben E A Musson
Comparison between coagulation factor VIII quantified with one-stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle. International journal of laboratory hematology 42 (6) (2020)

Anouk A M T Donners.css-eqlu8i{font-size:small;padding-left:4px;} (Anouk Donners)

Publication Activity (10 Years)

Top Topics

Top Venues

Anouk A M T Donners (Anouk Donners)